2022 International Congress Archives - Page 118 of 153

RE-EMERGENT TREMOR IN ESSENTIAL TREMOR; A PLUS SIGN FOR ET PLUS ?

E. Sanesteban Beceiro, P. Mayo Rodríguez, A. Fernández Revuelta, V. Gómez Mayordomo, E. López Valdés, R. García-Ramos, F. Alonso Frech (Madrid, Spain)
Real-World Clinical Utilization Differences of onabotulinumtoxinA and abobotulinumtoxinA in Upper Limb Spasticity

M. Nelson, A. Zuzek, M. Schwartz, R. Singh (Irvine, USA)
Real-World Deep Brain Stimulation Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control

T. Zesiewicz, M. Barbe, S. Paschen, C. Luca, C. Zhao, F. Ponce, J. Durphy, J. Ostrem, N. Tomycz, T. Prell, M. Siddiqui, L. Chen, R. Jain (Tampa, USA)
Real-world evidence and feasibility of telemedicine for Parkinson’s disease

G. Rigas, N. Kostikis, N. Tachos, E. Kontogiannis, E. Kostoulas, A. Bousis, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)
Real-World Outcomes Using a Novel Directional Lead from a Multicenter DBS Registry for Parkinson’s Disease

G. Deuschl, R. Jain, J. Wang, M. Barbe, S. Paschen, C. Sik Lee, J. Volkmann, A. Kühn, J. Vesper (Kiel, Germany)
Real-world sit-to-stand evaluation

C. Morgan, A. Masullo, H. Isotalus, E. Tonkin, M. Mirmehdi, F. Jovan, T. Whone, G. Oikonomou, R. Mcconville, G. Tourte, K. Kinnunen, I. Craddock (Bristol, United Kingdom)
Real-World Treatment Patterns and Outcomes in Patients With Chorea Associated With Huntington Disease Using Tetrabenazine or Deutetrabenazine in Combination with Antipsychotic Drugs

D. Claassen, H. Romdhani, R. Ayyagari, D. Goldschmidt, S. Zoye Moroz, A. Hernandez, S. Leo (Nashville, USA)
Reconfiguration of Functional Motor Connectome after MRgFUS Vim Thalamotomy in Essential Tremors

M. Stanziano, S. Palermo, JP. Medina, G. Demichelis, D. Fedeli, G. Messina, N. Golfrè Andreasi, S. Rinaldo, A. Redolfi, G. Devigili, V. Levi, F. Ghielmetti, G. Frazzetta, L. D'Incerti, M. Grisoli, F. Di Meco, A. Nigri, MG. Bruzzone, R. Eleopra (Milan, Italy)
Reduced metacognition of voluntary movements in functional movement disorders

F. Chwolka, J. Verrel, J. Moyé, S. Zittel, E. Filevich, T. Paulus, T. Bäumer, A. Münchau, A. Weissbach (Lübeck, Germany)
Reduced Risk of Mortality and Antipsychotics in Parkinson’s Disease-Related Psychosis: Pimavanserin vs Off-Label Antipsychotics

S. Isaacson, F. Pagan, D. Truong, V. Abler, R. Pahwa (Boca Raton, USA)